AI Summary CellCept (mycophenolate mofetil) is an immunosuppressive medication used to prevent organ rejection after liver transplantation, usually alongside a calcineurin inhibitor and a corticosteroid.
Medically reviewed.
CellCept (mycophenolate mofetil) is an immunosuppressive medication used to prevent organ rejection after liver transplantation. It is commonly taken together with a calcineurin inhibitor and a corticosteroid as part of a multi-drug regimen. CellCept lowers the immune activity that can damage the transplanted liver, which supports long-term graft (transplanted liver) function. Treatment decisions should always be individualized and guided by your transplant team.
This page covers CellCept's role after liver transplantation — how it works, who may be prescribed it, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT CELLCEPT TREATMENT
CellCept is a prescription medicine that contains mycophenolate mofetil. It belongs to a group of medicines called immunosuppressants, which lower the activity of the immune system. After a liver transplant, the immune system can see the new liver as foreign and attack it. This is called rejection.
CellCept helps prevent rejection. It is commonly used with a calcineurin inhibitor, such as Prograf (tacrolimus) or Neoral / Gengraf (cyclosporine), and with corticosteroids. Together, these medicines form a multi-drug regimen.
CellCept comes as capsules, tablets, an oral suspension, and an intravenous (IV) form. It is used with regular monitoring by your transplant team, including blood cell counts and liver function checks.
WHO CELLCEPT MAY BE SUITABLE FOR
Your transplant team decides whether CellCept fits your care. It may be prescribed if you have received a liver transplant and need combination immunosuppressive therapy. It may also be added when you need extra protection against rejection, when your regimen calls for a steroid-sparing medicine (one that may allow a lower corticosteroid dose), or when your team wants to support long-term graft survival.
Your medical history, blood test results, current medicines, and how well you tolerate treatment all play a part. Because every transplant recipient is different, there is no one-size-fits-all answer. Decisions should be made by a qualified healthcare professional after a full assessment of your transplant care and treatment goals.
ELIGIBILITY OVERVIEW
CellCept may be considered for people with the following conditions or treatment goals:
Before and during CellCept treatment, your transplant team reviews several factors, including:
HOW CELLCEPT CAN HELP YOUR TRANSPLANTED LIVER
CellCept slows the growth of T- and B-lymphocytes. These are white blood cells that drive the immune response. With fewer of these cells active, the immune system is less likely to attack the transplanted liver.
This helps prevent acute rejection and supports long-term graft function. CellCept also complements other immunosuppressive medicines, so your team can build a regimen that fits you.
CellCept is not used on its own. Providers pair it with other immunosuppressants and follow you with regular blood tests and visits to check how your body and your new liver are doing.
TRANSPLANT BENEFITS
CellCept slows the growth of T- and B-lymphocytes. These are white blood cells that drive the immune response. By slowing them, CellCept reduces immune responses that can damage the transplanted liver, so your body is less likely to treat the new organ as a threat.
CellCept helps prevent acute rejection and supports graft function. The graft is the transplanted liver. Your team checks your blood cell counts, liver function, and signs of infection regularly to keep this effect on track.
Ongoing immunosuppression supports long-term graft survival, which means keeping the transplanted liver working over time. CellCept is generally used as a long-term or lifelong therapy and is commonly continued indefinitely. Your team may change the dose or the medicine if side effects, complications, or changes to your regimen require it.
After a liver transplant, you may need combination immunosuppressive therapy, and your transplant team builds that plan around you. CellCept complements other immunosuppressive medicines, such as a calcineurin inhibitor and a corticosteroid. It works best when your team guides how it is used.
CellCept works by slowing the immune activity that can cause rejection. It should only be started, adjusted, and monitored by your transplant team.
TREATMENT PROCESS
CellCept is available as capsules, tablets, an oral suspension, and an intravenous (IV) form. Take it exactly as prescribed, and check with your pharmacist if you have questions about your specific form.
Most people take CellCept by mouth, with or without food. The IV form is used in some situations and is given by healthcare professionals. Take every dose as prescribed and do not miss doses.
The typical adult dose after liver transplantation is 1,500 mg twice daily (3,000 mg a day in total). Your transplant team may adjust the dose based on how well you tolerate it and how you respond. Do not change your dose without medical guidance.
CellCept is generally used as a long-term or lifelong maintenance therapy after liver transplantation. It is commonly continued indefinitely unless side effects, complications, or changes to your regimen require a dose change or a different medicine. Do not stop taking it without talking to your transplant team.
Store CellCept at room temperature, away from moisture and heat.
Your transplant team will regularly check your blood cell counts, liver function, and signs of infection. Keep all follow-up appointments and lab tests, and report side effects or unusual symptoms right away.
BENEFITS AND SAFETY
CellCept (mycophenolate mofetil) helps protect a transplanted liver by lowering the immune activity that causes rejection. It works with other immunosuppressants, may reduce corticosteroid needs, and supports long-term graft function. The benefit varies from person to person. CellCept is not a stand-alone treatment. It works as part of a regimen that your transplant team monitors with regular blood tests and visits.
As with any medication, CellCept may cause side effects. Because it lowers immune activity, it can raise your risk of infection and can lower your white blood cell count. Your transplant team will monitor you throughout treatment and adjust your care as needed to balance benefits against risks.
BENEFITS
CellCept helps protect your transplanted liver from acute rejection. This protection is the main reason it is prescribed after liver transplantation.
CellCept works with other immunosuppressants, so your team can build a regimen that fits you and adds protection against rejection.
CellCept may reduce how much corticosteroid you need. Your transplant team decides whether a change to your corticosteroid dose is right for you.
CellCept helps maintain graft function over time. It is generally used as a long-term or lifelong maintenance therapy and is commonly continued indefinitely. Your team may change the dose or the medicine if side effects, complications, or changes to your regimen require it.
Call your transplant team if you have signs of infection or side effects that bother you. Your team will discuss the benefits and risks of CellCept with you and provide ongoing support, including regular blood tests, to help you use it safely.
SUPPORTING YOUR RESULTS
Lifestyle changes are an important part of a comprehensive treatment plan alongside CellCept. Because the medicine lowers immune activity, your daily habits can help lower your infection risk and protect your transplant health.
These habits can support how your body responds to treatment and help your transplant team spot problems early.
Areas that may support treatment:
Common questions
CellCept helps prevent rejection after a liver transplant. It is an immunosuppressant that slows T- and B-lymphocytes, the white blood cells that drive the immune response, so your immune system is less likely to attack the new liver. It is commonly taken with a calcineurin inhibitor and a corticosteroid, not on its own. Ask your transplant team how CellCept fits your care plan.
CellCept may be prescribed if you have received a liver transplant and need combination immunosuppressive therapy. Your team may also add it when you need extra protection against rejection, when your regimen calls for a steroid-sparing medicine, or when they want to support long-term graft survival. Your medical history, test results, other medicines, and how well you tolerate treatment all matter. Only your transplant team can decide if CellCept suits you.
Usually a long time, often for life. CellCept is generally used as long-term maintenance therapy after liver transplantation and is commonly continued indefinitely. Your team may change your dose or switch medicines if side effects, complications, or changes to your regimen require it. Do not stop taking CellCept or change your dose on your own. Talk with your transplant team about what to expect over time.
The most common side effects are diarrhea, nausea, and abdominal discomfort. CellCept can also lower your white blood cell count and raise your risk of infection. Your team regularly checks your blood cell counts, liver function, and signs of infection. Report side effects to your transplant team instead of changing your dose yourself. They can help you weigh the benefits and risks for your situation.
Yes, CellCept can raise your risk of infection because it lowers immune activity. Wash your hands often and avoid close contact with people who are sick. Avoid live vaccines unless your transplant team approves them. Tell your team right away if you notice signs of infection. Your team also monitors blood cell counts and signs of infection at regular visits, so keep every appointment and lab test.
No. Liver disease guidance lists mycophenolic acid products, which include mycophenolate, as contraindicated in pregnancy and lactation. Talk with your transplant team before you plan a pregnancy or breastfeeding. Do not stop taking CellCept on your own. Your team can review safer options and timing with you and support your care plan. Personalized advice matters here because every transplant recipient is different.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
